- Home
- ABEO vs PKOH Comparison
ABEO vs PKOH Comparison
Compare ABEO & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- PKOH
- Stock Information
- Founded
- ABEO 1974
- PKOH 1907
- Country
- ABEO United States
- PKOH United States
- Employees
- ABEO N/A
- PKOH N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- PKOH Industrial Specialties
- Sector
- ABEO Health Care
- PKOH Industrials
- Exchange
- ABEO Nasdaq
- PKOH Nasdaq
- Market Cap
- ABEO 256.9M
- PKOH 282.2M
- IPO Year
- ABEO 1980
- PKOH N/A
- Fundamental
- Price
- ABEO $6.49
- PKOH $19.64
- Analyst Decision
- ABEO Strong Buy
- PKOH
- Analyst Count
- ABEO 5
- PKOH 0
- Target Price
- ABEO $17.80
- PKOH N/A
- AVG Volume (30 Days)
- ABEO 1.7M
- PKOH 27.9K
- Earning Date
- ABEO 05-15-2025
- PKOH 05-06-2025
- Dividend Yield
- ABEO N/A
- PKOH 2.77%
- EPS Growth
- ABEO N/A
- PKOH 144.68
- EPS
- ABEO N/A
- PKOH 2.26
- Revenue
- ABEO N/A
- PKOH $1,644,000,000.00
- Revenue This Year
- ABEO N/A
- PKOH $1.80
- Revenue Next Year
- ABEO $383.07
- PKOH $4.21
- P/E Ratio
- ABEO N/A
- PKOH $6.17
- Revenue Growth
- ABEO N/A
- PKOH N/A
- 52 Week Low
- ABEO $3.93
- PKOH $17.58
- 52 Week High
- ABEO $7.32
- PKOH $34.50
- Technical
- Relative Strength Index (RSI)
- ABEO 60.27
- PKOH 38.19
- Support Level
- ABEO $5.93
- PKOH $17.77
- Resistance Level
- ABEO $7.17
- PKOH $20.64
- Average True Range (ATR)
- ABEO 0.41
- PKOH 0.71
- MACD
- ABEO -0.00
- PKOH -0.13
- Stochastic Oscillator
- ABEO 63.44
- PKOH 17.97
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.